Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis
- PMID: 30393820
- DOI: 10.1007/s00701-018-3711-9
Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis
Abstract
Introduction: Radiosurgery (RS) and fractionated radiotherapy (FRT) are part of the therapeutic armamentarium for the management of cavernous sinus meningiomas. We propose a systematic review of the local tumor control and clinical outcomes after monofractionated radiosurgical treatment, including gamma knife radiosurgery (GKRS) and linear accelerator (Linac RS), or fractionated radiotherapy.
Materials and methods: The current review and meta-analysis adhered to the PRISMA guidelines. We performed a search in PubMed, Embase, and Medline based on the following mesh terms, used alone or in diverse combinations, in both title and abstract: "cavernous sinus," "meningioma," "radiosurgery," "gamma knife," "linac," "cyberknife," and "radiotherapy". We screened 425 studies. We selected 36 studies, matching all selection criteria: 24 for GK, 5 for Linac, and 7 for FRT.
Results: Were included 2817 patients (GKRS, n = 2047, LinacRS, n = 350, FRT, n = 420). Half of patients benefited from upfront RS or FRT; the other half benefited from adjuvant RS or FRT (combined approach or tumor recurrence). The mean gross target volume (GTV) was smaller for RS as compared to FRT (p = 0.07). The median marginal doses were 13.9 Gy (range, 11 to 28) for GKRS and 14 Gy (range, 12.8 to 17.7) for LinacRS. For FRT, patients received a mean dose of 51.2 Gy (25.5 fractions, 1.85 Gy each). The mean overall follow-up values were 48 months (range, 15 to 89) for GKRS, 69 months (range, 46 to 87) for Linac, and 59.5 months (range, 33 to 83) for FRT. PFS at 5 years for GKRS, LinacRS, and FRT were respectively 93.6%, 95.6%, and 97.4% (p = 0.32, the Kruskal-Wallis). Monofractionated treatments (GKRS and LinacRS) induced more tumor volume regression than FRT (p = 0.001). Tumor recurrence or progression ranged between 3 and 5.8%, without statistically significant differences between modalities (p > 0.05). Trigeminal symptoms improved in approximately 54%, and III-IV-VI cranial nerves (CN) palsies improved in approximately 45%. After GKRS, visual acuity improved in 21% (not enough data available for other modalities). De novo deficits occurred in 5 to 7.5%. Adverse radiation effects appeared in 4.6 to 9.3% (all techniques pooled).
Conclusion: RS achieved a twice-higher rate of tumor volume regression than FRT. GKRS series reported an improvement in visual acuity in 21% of the cases. GKRS, Linac, and FRT provided similar clinical post therapeutic outcomes for the trigeminal and oculomotor CN.
Keywords: Cavernous sinus meningioma; Gamma knife; Radiosurgery; Radiotherapy.
Similar articles
-
Single-Fraction Gamma-Knife Radiosurgery with or without Previous Surgery for Cavernous Sinus Meningiomas: A Single-Center Experience and Systematic Literature Review.Niger J Clin Pract. 2023 May;26(5):545-551. doi: 10.4103/njcp.njcp_2033_21. Niger J Clin Pract. 2023. PMID: 37357468
-
Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes.Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4. doi: 10.1227/01.neu.0000124750.13721.94. Neurosurgery. 2004. PMID: 15157295
-
Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.J Neurosurg. 2016 Dec;125(Suppl 1):89-96. doi: 10.3171/2016.7.GKS161521. J Neurosurg. 2016. PMID: 27903189
-
Fractionated Gamma Knife radiosurgery for skull base meningiomas: a single-institution experience.Neurosurg Focus. 2019 Jun 1;46(6):E8. doi: 10.3171/2019.3.FOCUS1963. Neurosurg Focus. 2019. PMID: 31153152
-
Efficacy and safety of gamma knife radiosurgery for posterior cranial fossa meningioma: a systematic review.Neurosurg Rev. 2020 Aug;43(4):1089-1099. doi: 10.1007/s10143-019-01144-x. Epub 2019 Aug 5. Neurosurg Rev. 2020. PMID: 31385110
Cited by
-
Identification and Management of Aggressive Meningiomas.Front Oncol. 2022 Mar 23;12:851758. doi: 10.3389/fonc.2022.851758. eCollection 2022. Front Oncol. 2022. PMID: 35402234 Free PMC article. Review.
-
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas.Clin Transl Radiat Oncol. 2023 Apr 24;41:100631. doi: 10.1016/j.ctro.2023.100631. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37168253 Free PMC article.
-
Gamma knife stereotactic radiosurgery for neurofibromatosis 2 (NF2)-associated meningiomas; a systematic review and meta-analysis.Acta Neurochir (Wien). 2025 Feb 5;167(1):35. doi: 10.1007/s00701-025-06436-4. Acta Neurochir (Wien). 2025. PMID: 39907804 Free PMC article.
-
Stereotactic Therapies for Meningiomas.Adv Exp Med Biol. 2023;1416:107-119. doi: 10.1007/978-3-031-29750-2_9. Adv Exp Med Biol. 2023. PMID: 37432623
-
Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01).BMC Cancer. 2024 Dec 30;24(1):1594. doi: 10.1186/s12885-024-13353-9. BMC Cancer. 2024. PMID: 39736544 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources